| Infusion of clinical‐grade enriched regulatory T cells delays experimental xenogeneic graft‐versus‐host disease M Hannon, C Lechanteur, S Lucas, J Somja, L Seidel, L Belle, F Bruck, ... Transfusion 54 (2), 353-363, 2014 | 76 | 2014 |
| Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease F Bruck, L Belle, C Lechanteur, L De Leval, M Hannon, S Dubois, ... Cytotherapy 15 (3), 267-279, 2013 | 53 | 2013 |
| Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression L Belle, K Agle, V Zhou, C Yin-Yuan, R Komorowski, D Eastwood, ... Blood 128 (16), 2068-2082, 2016 | 48 | 2016 |
| Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation S Servais, Y Beguin, L Delens, G Ehx, G Fransolet, M Hannon, E Willems, ... Expert opinion on investigational drugs 25 (8), 957-972, 2016 | 34 | 2016 |
| A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease V Zhou, K Agle, X Chen, A Beres, R Komorowski, L Belle, C Taylor, F Zhu, ... The Journal of Clinical Investigation 126 (9), 3541-3555, 2016 | 33 | 2016 |
| Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD L Belle, V Zhou, KL Stuhr, M Beatka, EM Siebers, JM Knight, MW Lawlor, ... JCI insight 2 (14), 2017 | 17 | 2017 |
| Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation M Binsfeld, Y Beguin, L Belle, E Otjacques, M Hannon, A Briquet, ... PloS one 9 (11), e113764, 2014 | 16 | 2014 |
| Imatinib and nilotinib inhibit hematopoietic progenitor cell growth, but do not prevent adhesion, migration and engraftment of human cord blood CD34+ cells L Belle, F Bruck, J Foguenne, A Gothot, Y Beguin, F Baron, A Briquet PloS one 7 (12), e52564, 2012 | 16 | 2012 |
| Thinking Out of the Box—New Approaches to Controlling GVHD F Baron, S Humblet-Baron, G Ehx, S Servais, M Hannon, L Belle, ... Current hematologic malignancy reports 9 (1), 73-84, 2014 | 9 | 2014 |
| Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease L Belle, G Fransolet, J Somja, M Binsfeld, P Delvenne, P Drion, M Hannon, ... PloS one 11 (12), e0167997, 2016 | 2 | 2016 |
